← FDA DRUG APPROVALS

FDA NDA · NDA220256

JAVADIN

clonidine hydrochloride oral

Sponsor: AZURITY

APPLICATION
NDA220256
TYPE
NDA
ORIGINAL APPROVAL
2025-10-23
LATEST ACTION
2025-10-23
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

JAVADIN · ReferencePrescription
CLONIDINE HYDROCHLORIDE 0.02MG/ML · SOLUTION · ORAL

Approval history

2025-10-23Type 3 - New Dosage Form · Original · standardLabelAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →